Form 4: Genpact Director Tamara Franklin Increases Stake Through RSU Grant

Genpact Director Tamara Franklin was granted 4,825 unvested restricted share units, increasing her beneficial ownership to 24,986 common shares.

Summary

• Tamara Franklin, a Director of Genpact LTD, acquired 4,825 common shares on May 22, 2025.
• These shares were granted in the form of unvested restricted share units (RSUs) under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• Each RSU entitles the holder to receive one common share at a future date.
• The RSUs will fully vest on December 31, 2025, contingent on Ms. Franklin's continued service.
• The RSUs are scheduled to be settled in common shares on December 31, 2026.
• The acquisition price for these RSUs was $0, which is typical for equity compensation grants.
• Following this transaction, Tamara Franklin's total beneficial ownership in Genpact LTD stands at 24,986 common shares.

Sentiment

Score: 7

Explanation: The grant of restricted share units to a director is a positive signal of alignment between management and shareholder interests, as the compensation is tied to future company performance. However, it is a routine compensation event rather than a significant operational or financial announcement that would dramatically alter the company's outlook.

Positives

• The grant of 4,825 restricted share units to Director Tamara Franklin aligns her interests with those of shareholders, as the value of these units is directly tied to the company's future share price performance.
• The increase in beneficial ownership to 24,986 common shares demonstrates continued commitment and confidence from a key board member in the company's long-term prospects.

Future Outlook

The granted restricted share units are scheduled to fully vest on December 31, 2025, and will be settled in common shares on December 31, 2026, contingent on the reporting person's continued service.

Industry Context

This Form 4 filing is a standard disclosure of an insider equity transaction, common across all publicly traded companies as part of executive and director compensation practices. It does not provide broader industry context beyond the company's routine operations.

Comparison to Industry Standards

• The grant of restricted share units to a director is a common form of equity compensation in publicly traded companies, aligning executive incentives with shareholder value.
• While specific grant sizes vary by company size, industry, and individual roles, the mechanism of granting RSUs with vesting conditions is a widely adopted standard practice in corporate governance and compensation.

Corporate Governance

Related Party Transactions

• The grant of restricted share units to Tamara Franklin, a Director of Genpact LTD, constitutes a related party transaction as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with those of shareholders, potentially leading to more focused efforts on long-term value creation.
• Employees: No direct impact on general employees is indicated by this specific filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this specific filing.

Next Steps

• The granted RSUs are expected to fully vest on December 31, 2025.
• The vested RSUs are expected to be settled in common shares on December 31, 2026.

Key Dates

Recommendation

Keywords

Genpact, G, SEC Form 4, Insider Transaction, Restricted Share Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership